Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

With a new foreword by Nora Volkow, Director of the National Institute on Drug Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use Disorder provides updated information on evidence-based treatment for opioid use disorder (OUD)—an increasingly important topic as the epidemic of opioid misuse and overdose deaths grows in the United States. Bulleted clinical pearls at the end of each chapter, as well as specific clinical recommendations and detailed case discussions throughout, make it easier for readers to retain knowledge and integrate it into their clinical practice. The guide also features sample documentation and scales, including a treatment contract and a patient consent, that can be used to model documents in practice. This new edition of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5 language, and two additional chapters have been included: one that addresses other pharmacotherapies useful in treating OUD, including methadone and naltrexone, and another that discusses OUD treatment specifically with regard to women’s health and pregnancy. A discussion of the Comprehensive Addiction and Recovery Act (CARA). Advice for working with Alcoholics Anonymous and Narcotics Anonymous. A discussion on integrating buprenorphine into residential and inpatient opioid treatment programs. -- Publisher

Opioid abuse --- Buprenorphine --- Analgesics --- Morphine --- Narcotic antagonists --- Opioid addiction --- Opioid habit --- Drug abuse --- Chemotherapy. --- Therapeutic use. --- Derivatives --- Opioid-Related Disorders --- Opiate Substitution Treatment. --- Medication Assisted Treatment of Opioid --- Opiate Medication-Assisted Treatment --- Opioid Medication Assisted Treatment --- Opioid Replacement Therapy --- Opioid Substitution Therapy --- Opioid Substitution Treatment --- Opiate Replacement Therapy --- Medication-Assisted Treatment, Opiate --- Opiate Medication Assisted Treatment --- Opiate Medication-Assisted Treatments --- Opiate Replacement Therapies --- Opiate Substitution Treatments --- Opioid Replacement Therapies --- Opioid Substitution Therapies --- Opioid Substitution Treatments --- Replacement Therapy, Opiate --- Replacement Therapy, Opioid --- Substitution Therapy, Opioid --- Substitution Treatment, Opiate --- Substitution Treatment, Opioid --- Therapy, Opioid Substitution --- Methadone --- 6029-M --- Buprenex --- Buprenorphine Hydrochloride --- Buprex --- Prefin --- RX-6029-M --- Subutex --- Temgesic --- Temgésic --- 6029 M --- 6029M --- Hydrochloride, Buprenorphine --- RX 6029 M --- RX6029M --- Opiate Substitution Treatment --- Addiction, Opioid --- Dependence, Opioid --- Opiate Abuse --- Opioid Abuse --- Opioid Addiction --- Opioid Dependence --- Opiate Addiction --- Opiate Dependence --- Abuse, Opiate --- Abuse, Opioid --- Abuses, Opiate --- Abuses, Opioid --- Addiction, Opiate --- Addictions, Opioid --- Dependence, Opiate --- Dependences, Opioid --- Opiate Abuses --- Opioid Abuses --- Opioid Addictions --- Opioid Dependences --- Opioid Related Disorders --- Opioid-Related Disorder --- Analgesics, Opioid --- Narcotics --- Opioid Maintenance Treatment --- Maintenance Treatment, Opioid --- Opioid Maintenance Treatments --- Treatment, Opioid Maintenance --- Opioid Misuse --- Opioid Use Disorder --- Prescription Opioid Abuse --- Prescription Opioid Misuse --- Abuse, Prescription Opioid --- Disorder, Opioid Use --- Misuse, Opioid --- Misuse, Prescription Opioid --- Opioid Abuse, Prescription --- Opioid Misuses --- Opioid Use Disorders --- Prescription Opioid Abuses --- Prescription Opioid Misuses --- drug therapy. --- therapeutic use. --- drug therapy --- therapeutic use